Answers are grounded in this paper and cite their sources.
Systematic phenotyping enhances outcomes in children with T2-low asthma, suggesting improved precision medicine approaches.
Systematic T2-low phenotyping in pediatric practice, alongside prospective studies and non-T2 therapy trials, promises precision medicine to enhance outcomes for these children, moving beyond eosinophil-centric care.
No takes yet. Share an insight, caveat, or question.
Kobal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: